| Journals Medical Newsletter for Monday January 26, 2026 ( 4 items ) |
|
Iraq & Afghanistan Veterans CEO Hunter Testifies Before House Veterans' Affairs Subcommittee
WASHINGTON, Jan. 26 -- The House Veterans' Affairs Subcommittee on Disability Assistance and Memorial Affairs Oversight released the following testimony by Kyleanne Hunter, CEO of Iraq and Afghanistan Veterans of America, from a Jan. 14, 2026, hearing entitled "Reevaluating the Rating Schedule: Examining VA's Efforts to Modernize Disability Benefits":
* * *
Chairman Luttrell, Ranking Member McGarvey, and Members of the Subcommittee, thank you for the opportunity to testify today. My name is, D
more
Michigan Medicine: IVF Insurance Coverage Varies Greatly Among Larger Employers
ANN ARBOR, Michigan, Jan. 25 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
IVF insurance coverage varies greatly among larger employers
Analysis of in vitro fertilization policy plans offers a better picture of what kind of access patients actually have
*
With President Trump's executive order to expand access to families for in vitro fertilization, or IVF, the federal government has been giving special att
more
Rand Senior Economist Armour Testifies Before House Veterans' Affairs Subcommittee
WASHINGTON, Jan. 26 -- The House Veterans' Affairs Subcommittee on Disability Assistance and Memorial Affairs Oversight released the following testimony by Philip Armour, a senior economist at Rand, from a Jan. 14, 2026, hearing entitled "Reevaluating the Rating Schedule: Examining VA's Efforts to Modernize Disability Benefits":
* * *
Chairman Luttrell, Ranking Member McGarvey, and members of the committee, thank you for your invitation to testify. My name is Dr. Philip Armour. I am a senior e
more
Reversing Immune Suppression in Pancreatic Cancer Could Lead to Novel Therapies
WASHINGTON, Jan. 20 (TNSjou) -- The Georgetown University Medical Center issued the following news:
* * *
Reversing Immune Suppression in Pancreatic Cancer Could Lead to Novel Therapies
In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer cells send out tiny particles that are packed with certain microRNA molecules, nearby immune cells called macrophages are reprogrammed to help the tumor grow instead of engaging in their
more
|
Sign up to Receive this newsletter every day via email.
